Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release

Brain Research

Volumn 785, Issue 2, 1998, Pages 195-206

  Hu, Jingru ^a   Akama, Keith T ^a   Krafft, Grant A ^a,b   Chromy, Brett A ^c   Van Eldik, Linda J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Evanston NW Hlthcare Res Inst   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Astrocyte; Beta amyloid; Interleukin 1; Nitric oxide synthase

Indexed keywords

AMYLOID BETA PROTEIN; COMPLEMENTARY DNA; CYTOKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SYNTHETIC PEPTIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DEGENERATIVE DISEASE; IMMUNOHISTOCHEMISTRY; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RAT;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; CYTOKINES; ENZYME INDUCTION; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN-1; MICROSCOPY, ATOMIC FORCE; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0032473596     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01318-8     Document Type: Article

References (48)

1. Cairns N.J., Chadwick A., Luthert P.J., Lantos P.L. Astrocytosis, beta A4-protein deposition and paired helical filament formation in Alzheimer's disease. J. Neurol. Sci. 112:1992;68-75.
2. Canning D.R., McKeon R.J., DeWitt D.A., Perry G., Wujek J.R., Frederickson R.C.A., Silver J. Beta-amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp. Neurol. 124:1993;289-298.
3. Chao C.C., Hu S., Peterson P.K. Glia, cytokines and neurotoxicity. Crit. Rev. Neurobiol. 9:1995;189-205.
4. Chao C.C., Hu S., Sheng W.S., Bu D., Bukrinsky M.I., Peterson P.K. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. Glia. 16:1996;276-284.
5. Cotman C.W., Su J.H. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol. 6:1996;493-506.
6. Cotman C.W., Tenner A.J., Cummings B.J. Beta-amyloid converts an acute phase injury response to chronic injury responses. Neurobiol. Aging. 17:1996;723-731.
7. Das S., Potter H. Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1. Neuron. 14:1995;447-456.
8. del Bo R., Angeretti N., Lucca E., de Simoni M.G., Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures. Neurosci. Lett. 188:1995;70-74.
9. Eddleston M., Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience. 54:1993;15-36.
10. Galea E., Reis D.J., Feinstein D.L. Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37:1994;406-414.
11. Gitter B.D., Cox L.M., Rydel R.E., May P.C. Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells. Proc. Natl. Acad. Sci. U.S.A. 92:1995;10738-10741.
12. Gray C.W., Patel A.J. Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes. Mol. Brain Res. 19:1993;251-256.
13. Griffin W.S.T., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L. III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 86:1989;7611-7615.
14. W.S.T. Griffin, L.C. Stanley, Glial activation as a common denominator in neurodegenerative disease: a hypothesis in neuropathophysiology, in: Federoff et al. (Eds.), Biology and Pathology of Astrocyte-Neuron Interactions, Plenum, New York, 1993, pp. 359-381.
15. Griffin W.S.T., Sheng J.G., Roberts G.W., Mrak R.E. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54:1995;276-281.
16. Gross S.S., Wolin M.S. Nitric oxide: pathophysiological mechanisms. Ann. Rev. Physiol. 57:1995;737-769.
17. Höke A., Canning D.R., Malemud C.J., Silver J. Regional differences in reactive gliosis induced by substrate-bound beta-amyloid. Exp. Neurol. 130:1994;56-66.
18. Hu J., Van Eldik L.J. S100β induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim. Biophys. Acta. 1313:1996;239-245.
19. Hu J., Ferreira A., Van Eldik L.J. S100β induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69:1997;2294-2301.
20. Hu J., Castets F., Guevara J.L., Van Eldik L.J. S100β stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes. J. Biol. Chem. 271:1996;2543-2547.
21. S.W. Levison, K.D. McCarthy, Astroglia in culture, in: G. Banker, K. Goslin (Eds.), Culturing Nerve Cells, MIT Press, Cambridge, MA, 1991, pp. 309-336.
22. Liu W., Shafit-Zagardo B., Aquino D.A., Zhao M.-L., Dickson D.W., Brosnan C.F., Lee S.C. Cytoskeletal alterations in human fetal astrocytes induced by interleukin-1 beta. J. Neurochem. 63:1994;1625-1634.
23. Loo D.T., Copani A., Pike C.J., Whittemore E.R., Walencewicz A.J., Cotman C.W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7951-7955.
24. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
25. Marshak D.R., Pesce S.A., Stanley L.C., Griffin W.S.T. Increased S100β neurotrophic activity in Alzheimer's disease temporal lobe. Neurobiol. Aging. 13:1991;1-7.
26. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
27. Meda L., Cassatella M.A., Szendrei G., Otvos L., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature. 374:1995;647-650.
28. Mrak R.E., Sheng J.G., Griffin W.S.T. Glial cytokines in Alzheimer's disease: review and pathogenic implications. Human Pathol. 26:1995;816-823.
29. Mrak R.E., Sheng J.G., Griffin W.S.T. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55:1996;273-279.
30. Murphy S., Grzybicki D. Glial NO: normal and pathological roles. The Neuroscientist. 2:1996;90-99.
31. Norton W.T., Aquino D.A., Hozumi I., Chiu F.-C., Brosnan C.F. Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17:1992;877-885.
32. Oda T., Wals P., Osterburg H.H., Johnson S.A., Pasinetti G.M., Morgan T.E., Rozovsky I., Stine W.B., Snyder S.W., Holzman T.F., Krafft G.A., Finch C.E. Clustering (apoJ) alters the aggregation of amyloid beta-peptide (Aβ 1-42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp. Neurol. 136:1995;22-31.
33. Pasinetti G.M. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol. Aging. 17:1996;707-716.
34. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13:1993;1676-1687.
35. Pike C.J., Cummings B.J., Monzavi R., Cotman C.W. Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience. 63:1994;517-531.
36. Pike C.J., Ramezan-Arab N., Miller S., Cotman C.W. Beta-amyloid increases enzyme activity and protein levels of glutamine synthetase in cultured astrocytes. Exp. Neurol. 139:1996;167-171.
37. Rogers J. Inflammation as a pathogenic mechanism in Alzheimer's disease. Arzneim. Forsch./Drug Res. 45:1995;439-442.
38. Roher A.E., Chaney M.O., Kuo Y.-M., Webster S.D., Stine W.B., Haverkamp L.J., Woods A.S., Cotter R.J., Tuohy J.M., Krafft G.A., Bonnell B.S., Emmerling M.R. Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271:1996;20631-20635.
39. Rossi F., Bianchini E. Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes. Biochem. Biophys. Res. Commun. 225:1996;474-478.
40. Salinero O., Moreno-Flores M.T., Ceballos M.L., Wandosell F. Beta-amyloid peptide induced cytoskeletal reorganization in cultured astrocytes. J. Neurosci. Res. 47:1997;216-223.
41. Selkoe D.J. The molecular pathology of Alzheimer's disease. Neuron. 6:1991;487-498.
42. Sheng J.G., Ito K., Skinner R.D., Mrak R.E., Rovnaghi C.R., Van Eldik L.J., Griffin W.S.T. In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. Neurobiol. Aging. 17:1996;761-766.
43. Smale G., Nichols N.R., Brady D.R., Finch C.E., Horton W.E. Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133:1995;225-230.
44. Snyder S.W., Ladror U.S., Wade W.S., Wang G.T., Barrett L.W., Matayoshi E.D., Huffaker H.J., Krafft G.A., Holzman T.F. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys. J. 67:1994;1216-1228.
45. Stine W.B. Jr., Snyder S.W., Ladror U.S., Wade W.S., Miller M.F., Perun T.J., Holzman T.F., Krafft G.A. The nanometer-scale structure of amyloid-beta visualized by atomic force microscopy. J. Prot. Chem. 15:1996;193-203.
46. Terry R.D. Neuropathological changes in Alzheimer disease. Prog. Brain Res. 101:1994;383-390.
47. Van Eldik L.J., Griffin W.S.T. S100 beta expression in Alzheimer's disease: relation to neuropathology in brain regions. Biochim. Biophys. Acta. 1223:1994;398-403.
48. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:1996;921-932.